Mar 24, 2017 at 10:17 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one can buy YES Bank, Aditya Birla Nuvo and Bata India and sell M&M and Apollo Hospitals.
Mar 08, 2017 at 15:23 | Source: CNBC-TV18
Prakash Gaba of prakashgaba.com is of the view that Divis Laboratories can climb to Rs 810 while HDFC Bank looks good.
Mar 08, 2017 at 15:21 | Source: CNBC-TV18
According to Sandeep Wagle of powermywealth.com, one can buy Divis Laboratories and sell Apollo Tyres.
Mar 08, 2017 at 14:43 | Source: CNBC-TV18
Mitessh Thakkar of miteshthacker.com recommends buying Divis Labs and Bharat Financial Inclusion.
Mar 08, 2017 at 13:24 | Source: CNBC-TV18
Prakash Gaba of prakashgaba.com is of the view that Divis Laboratories can climb to Rs 810 while Infosys looks weak.
Mar 08, 2017 at 12:11 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips, pharma stocks like Divis Lab, Cipla, Alembic Pharma, Strides Shasun, Ajanta Pharma and Torrent Pharma will get astro support.
Mar 08, 2017 at 11:32 | Source: CNBC-TV18
Mitessh Thakkar of miteshthacker.com is of the view that one can buy Kotak Mahindra Bank and NMDC.
Mar 05, 2017 at 11:57 | Source: Moneycontrol.com
Cipla has made many changes to its top leadership as it tries to catch up with other larger Indian generic rivals like Sun Pharma, Dr.Reddys, Lupin and Aurobindo in the US market who generate half their sales at much higher margins.
Mar 02, 2017 at 13:24 | Source: Moneycontrol.com
The index provider FTSE Russell will also add UPL, LIC Housing Finance and Piramal Enterprises to its large cap index. These changes will be effective from March 20, 2017.
Mar 01, 2017 at 10:37 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends buying Bata India at current level.